Abiopharma

🔍 Raghu Ravi (Executive)

Company: CAPITAL ONE FINANCIAL CORP (COF)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Sold 3,462 shares of Common Stock at $209.27 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,592.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,820 shares of Common Stock at $210.02 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,772.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 444 shares of Common Stock at $210.7 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,328.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: This transaction was executed pursuant to a trading plan entered into by the reporting person on April 23, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.59 to $209.57. Information regarding the number of shares sold at each price will be provided upon request.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.60 to $210.54. Information regarding the number of shares sold at each price will be provided upon request.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.63 to $210.89. Information regarding the number of shares sold at each price will be provided upon request.